Daijiworld Media Network - New Delhi

New Delhi, Nov 19: In a major leap for Atmanirbhar Bharat and India’s genomic medicine capabilities, the government on Wednesday launched the country’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, a condition that disproportionately affects tribal communities.

The therapy, named “BIRSA 101” in honour of tribal freedom fighter Bhagwan Birsa Munda, was unveiled by Union Minister of State for Science and Technology (Independent Charge) Dr. Jitendra Singh.

Describing the innovation as a form of “precise genetic surgery,” Dr. Singh said the platform has the potential not only to cure Sickle Cell Disease but also to revolutionise treatment for a range of inherited disorders.

Sickle Cell Disease is a severe genetic blood disorder ma

See Full Page